Imuracetam (INN ; developmental code name UCB-G218) is a drug of the racetam group described as a nootropic (cognitive enhancer).[2][3] It was under development in the 1970s but was never marketed.[1]
Names | |
---|---|
Preferred IUPAC name
N,N′-Bis[(2-oxopyrrolidin-1-yl)methyl]urea | |
Other names
UCB-G218
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C11H18N4O3 | |
Molar mass | 254.290 g·mol−1 |
Melting point | 184.5 °C (364.1 °F; 457.6 K)[1] |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
References
edit- ^ a b Ganellin CR, Triggle DJ (1996). Dictionary of Pharmacological Agents. Vol. 3. CRC Press.
- ^ Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 681. ISBN 978-1-4757-2085-3. Retrieved 1 October 2024.
- ^ Avetisyan SA, Kocharov SL, Azaryan LV, Dzhagatspanyan IA, Melikyan GG (February 1998). "Synthesis and psychotropic activity of new 2-pyrrolidone derivatives". Pharmaceutical Chemistry Journal. 32 (2): 55–58. doi:10.1007/BF02464161. S2CID 29810469.